Colonic bacterial metabolites and human health

Current Opinion in Microbiology

Volumn 16, Issue 3, 2013, Pages 246-254

  Russell, Wendy R ^a   Hoyles, Lesley ^b   Flint, Harry J ^a   Dumas, Marc Emmanuel ^b  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; AROMATIC AMINO ACID; AROMATIC COMPOUND; BETA GLUCURONIDASE; CARBOHYDRATE; CARNITINE; FERULIC ACID; METHYLAMINE; PHOSPHATIDYLCHOLINE; PLANT MEDICINAL PRODUCT; SHORT CHAIN FATTY ACID; XENOBIOTIC AGENT;

CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COLON FLORA; ENERGY RESOURCE; ENTEROHEPATIC CIRCULATION; FERMENTATION; HUMAN; INCIDENCE; INSULIN RESISTANCE; INTESTINE FLORA; LIVER; METABOLITE; NONALCOHOLIC FATTY LIVER; NONHUMAN; REVIEW; VITAMIN DEFICIENCY;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 84881550298     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.07.002     Document Type: Review

References (65)

1. Walker A.W., Ince J., Duncan S.H., Webster L.M., Holtrop G., Ze X., Brown D., Stares M.D., Scott P., Bergerat A., et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 2011, 5:220-230.
2. Wu G.D., Chen J., Hoffmann C., Bittinger K., Chen Y.-Y., Keilbaugh S.A., Bewtra M., Knights D., Walters W.A., Knight R., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334:105-108.
3. Claesson M.J., Jeffery I.B., Conde S., Power S.E., O'Connor E.M., Cusack S., Harris H.M.B., Coakley M., Lakshminarayanan B., O'Sullivan O., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012, 488:178-184.
4. Robertson M.D., Bickerton A.S., Dennis A.L., Vidal H., Frayn K.N. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 2005, 82:559-567.
5. Martínez I., Lattimer J.M., Hubach K.L., Case J.A., Yang J., Weber C.G., Louk J.A., Rose D.J., Kyureghian G., Peterson D.A., et al. Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J 2013, 7:269-280.
6. Louis P., Flint H.J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 2009, 294:1-8.
7. Louis P., Young P., Holtrop G., Flint H.J. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 2010, 12:304-314.
8. Flint H.J., Scott K.P., Louis P., Duncan S.H. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 2012, 9:577-589.
9. Nakamura N., Lin H.C., McSweeney C.S., Mackie R.I., Gaskins H.R. Mechanisms of microbial hydrogen disposal in the human colon and implications for health and disease. Curr Rev Food Sci Technol 2010, 1:363-395.
10. Cummings J.H. Short chain fatty acids. Human Colonic Bacteria: Role in Nutritional Physiology and Pathology 1995, 101-130. CRC Press, Boca Raton, FL. G.R. Gibson, G.T. Macfarlane (Eds.).
11. Zhu L., Baker S.S., Gill C., Liu W., Alkhouri R., Baker R.D., Gill S.R. Characterisation of gut microbiomes in non alcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatitis 2013, 57:601-609.
12. Maslowski K.M., Vieira A.T., Ng A., Kranich J., Sierro F., Yu D., Schilter H.C., Rolph M.S., Mackay F., Artis D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1286.
13. Fukuda S., Toh H., Hase K., Oshima K., Nakanishi Y., Yoshimura K., Tobe T., Clarke J.M., Topping D.L., Suzuki T., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469:543-547.
14. Matsuki T., Pedron T., Regnault B., Mulet C., Hara T., Sansonetti P.J. Epithelial cell proliferation arrest induced by lactate and acetate from Lactobacillus casei and Bifidobacterium breve. PLoS ONE 2013, 8:e63053.
15. Fung K.Y., Cosgrove L., Lockett T., Head R., Topping D.L. A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br J Nutr 2012, 108:820-831.
16. Nepelska M., Cultrone A., Beguet-Crespel F., Le Roux K., Dore J., Arulampalam V., Blottiere H.M. Butyrate produced by commensal bacteria potentiates phorbol esters induced AP-1 response in human intestinal cells. PLoS ONE 2012, 7:e52869.
17. Arora T., Sharma R., Frost G. Propionate. Anti-obesity and satiety enhancing factor?. Appetite 2011, 56:511-515.
18. Lin H.V., Frassetto A., Kowalik E.J., Nawrocki A.R., Lu M.M., Kosinski J.R., Hubert J.A., Szeto D., Yao X., Forrest G., et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 2012, 7:e35240.
19. Duncan S.H., Belenguer A., Holtrop G., Johnstone A.M., Flint H.J., Lobley G.E. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 2007, 73:1073-1078.
20. Russell W.R., Gratz S.W., Duncan S.H., Holtrop G., Ince J., Scobbie L., Duncan G., Johnstone A.M., Lobley G.E., Wallace R.J., et al. High protein, reduced carbohydrate weight loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr 2011, 93:1062-1072.
21. Abell G.C.J., Conlon M.A., McOrist A.L. Methanogenic archaea in adult fecal samples are inversely related to buytrate concentration. Microb Ecol Health Dis 2006, 18:154-160.
22. Duncan S.H., Louis P., Thomson J.M., Flint H.J. The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol 2009, 11:2112-2122.
23. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermudez Humaran L.G., Gratadoux J.J., Blugoen S., Bridonneau C., Furet J.P., Corthier G., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by the gut microbiota analysis of Crohn's disease patients. Proc Natl Acad Sci USA 2008, 105:16731-16736.
24. Wrzosek L., Miquel S., Noordine M.-L., Bouet S., Chevalier-Curt M.J., Robert V., Philippe C., Bridonneau C., Cherbuy C., Robbe-Maselot C., et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol 2013, 11:61.
25. Russell W.R., Duncan S.H., Flint H.J. The gut microbial metabolome: modulation of cancer risk in obese individuals. Proc Nutr Soc 2013, 72:178-188.
26. Russell W.R., Duthie G.G. Plant secondary metabolites and gut health: the case for phenolic acids. Proc Nutr Soc 2011, 70:389-396.
27. Russell W.R., Scobbie L., Chesson A., Richardson A.J., Stewart C.S., Duncan S.H., Drew J.E., Duthie G.G. Anti-inflammatory implications of the microbial transformation of dietary phenolic compounds. Nutr Cancer 2008, 60:636-642.
28. Gonthier M.P., Remesy C., Scalbert A., Cheynier V., Souquet J.M., Poutanen K., Aura A.M. Microbial metabolism of caffeic acid and its esters chlorogenic and caftaric acids by human faecal microbiota in vitro. Biomed Pharmacol 2006, 60:536-540.
29. Russell W.R., Drew J.E., Scobbie L., Duthie G.G. Inhibition of cytokine-induced prostanoid biogenesis by phytochemicals in human colonic fibroblasts. Biochim Biophys Acta Mol Basis Dis 2006, 1762:124-130.
30. Macfarlane G.T., Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC 2012, 95:50-60.
31. Russell W.R., Duncan S.H., Scobbie L., Duncan G., Cantlay L., Calder A.G., Anderson S.E., Flint H.J. Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. Mol Nutr Food Res 2013, 57:523-535.
32. Kuhnle G.G.C., Bingham S.A. Meats, protein and cancer. Bioactive Compounds and Cancer. Nutrition and Health Series 2010, 195-212. Humana Press, NJ, USA. J.A. Milner, D.F. Romognolo (Eds.).
33. Tomas-Barberan F.A., Andres-Lacueva C. Polyphenols and health: current state and progress. J Agric Food Chem 2012, 60:S8773-S8775.
34. McIntosh F.M., Maison N., Holtrop G., Young P., Stevens V.J., Ince J., Johnstone A.M., Lobley G.E., Flint H.J., Louis P. Phylogenetic distribution of genes encoding β-glucuronidase activity in human colonic bacteria and the impact of diet on faecal glycosidase activities. Environ Microbiol 2012, 14:1876-1887.
35. Gloux K., Berteau O., El Oumami H., Bequet F., Le Clerc M., Dore J. A metagenomic β-glucuronidase uncovers a core function of the human intestinal microbiome. Proc Natl Acad Sci U S A 2011, 108:4539-4546.
36. Compare D., Coccoli P., Rocco A., Nardone O.M., De Maria S., Cartenì M., Nardone G. Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2012, 22:471-476.
37. Le Roy T., Llopis M., Lepage P., Bruneau A., Rabot S., Bevilacqua C., Martin P., Philippe C., Walker F., Bado A., Perlemuter G., Cassard-Doulcier A.M., Gérard P. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 2012, 10.1136/gutjnl-2012-303816.
38. Zeisel S.H. Dietary choline: biochemistry, physiology, and pharmacology. Annu Rev Nutr 1981, 1:95-121.
39. Zeisel S.H., Da Costa K.A., Franklin P.D., Alexander E.A., Lamont J.T., Sheard N.F., Beiser A. Choline, an essential nutrient for humans. FASEB J 1991, 5:2093-2098.
40. Zeisel S.H., da Costa K.A. Choline: an essential nutrient for public health. Nutr Rev 2009, 67:615-623.
41. Gibellini F., Smith T.K. The Kennedy pathway-de novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life 2010, 62:414-428.
42. Zeisel S.H., Wishnok J.S., Blusztajn J.K. Formation of methylamines from ingested choline and lecithin. J Pharmacol Exp Ther 1983, 225:320-324.
43. Patterson K.Y., Bhagwat S.A., Williams J.R., Howe J.C., Holden J.M. USDA Database for the Choline Content of Common Foods. Release two 2008, http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/Choline/Choln02.pdf.
44. Chen H.L., Haack V.S., Janecky C.W., Vollendorf N.W., Marlett J.A. Mechanisms by which wheat bran and oat bran increase stool weight in humans. Am J Clin Nutr 1998, 68:711-719.
45. Cotton P.B. Non-dietary lipid in the intestinal lumen. Gut 1972, 13:675-681.
46. Norris E.R., Benoit G.J. Studies on trimethylamine oxide. III. Trimethylamine oxide excretion by the rat. J Biol Chem 1945, 158:443-448.
47. de la Huerga J., Popper H. Urinary excretion of choline metabolites following choline administration in normals and patients with hepatobiliary diseases. J Clin Invest 1951, 30:463-470.
48. de la Huerga J., Popper H. Factors influencing choline absorption in the intestinal tract. J Clin Invest 1952, 31:598-603.
49. al-Waiz M., Mikov M., Mitchell S.C., Smith R.L. The exogenous origin of trimethylamine in the mouse. Metabolism 1992, 41:135-136.
50. Bradbeer C. The clostridial fermentations of choline and ethanolamine. 1. Preparation and properties of cell-free extracts. J Biol Chem 1965, 240:4669-4674.
51. Lang D.H., Yeung C.K., Peter R.M., Ibarra C., Gasser R., Itagaki K., Philpot R.M., Rettie A.E. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3. Biochem Pharmacol 1998, 56:1005-1012.
52. Nicholson J.K., Holmes E., Wilson I.D. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 2005, 3:431-438.
53. Dumas M.E. The microbial-mammalian metabolic axis: beyond simple metabolism. Cell Metab 2011, 13:489-490.
54. Craciun S., Balskus E.P. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci U S A 2012, 109:21307-21312.
55. Koch-Weser D., de la Huerga J., Popper H. Effect of choline supplements on fatty metamorphosis and liver cell damage in choline and protein deficiency. J Nutr 1953, 49:443-452.
56. Zhang A.Q., Mitchell S.C., Smith R.L. Dietary precursors of trimethylamine in man: a pilot study. Food Chem Toxicol 1999, 37:515-520.
57. Dumas M.E., Barton R.H., Toye A., Cloarec O., Blancher C., Rothwell A., Fearnside J., Tatoud R., Blanc V., Lindon J.C., et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A 2006, 103:12511-12516.
58. Mouzaki M., Comelli E.M., Arendt B.M., Bonengel J., Fung S.K., Fischer S.E., McGilvray I.D., Allard J.P. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 2013, 10.1002/hep.26319.
59. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B., DeSimone C., Song X., Diehl A.M. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003, 37:343-350.
60. Henao-Mejia J., Elinav E., Jin C., Hao L., Mehal W.Z., Strowig T., Thaiss C.A., Kau A.L., Eisenbarth S.C., Jurczak M.J., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
61. Spencer M.D., Hamp T.J., Reid R.W., Fischer L.M., Zeisel S.H., Fodor A.A. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 2011, 140:976-986.
62. Hawksworth G., Hill M.J. The formation of nitrosamines by human intestinal bacteria. Biochem J 1971, 122:28P-29P.
63. Wang Z., Klipfell E., Bennett B.J., Koeth R., Levison B.S., Dugar B., Feldstein A.E., Britt E.B., Fu X., Chung Y.M., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472:57-63.
64. Tang W.H., Wang Z., Levison B.S., Koeth R.A., Britt E.B., Fu X., Wu Y., Hazen S.L. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013, 368:1575-1584.
65. Koeth R.A., Wang Z., Levison B.S., Buffa J.A., Org E., Sheehy B.T., Britt E.B., Fu X., Wu Y., Li L., et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013, 19:576-585.